Fred Alger Management, LLC Tandem Diabetes Care Inc Transaction History

Fred Alger Management, LLC

  • $20.1 Billion
  • Q2 2024

A detailed history of Fred Alger Management, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 2,174,107 shares of TNDM stock, worth $72.4 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
2,174,107
Previous 1,497,071 45.22%
Holding current value
$72.4 Million
Previous $53 Million 65.24%
% of portfolio
0.44%
Previous 0.27%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$30.43 - $53.43 $20.6 Million - $36.2 Million
677,036 Added 45.22%
2,174,107 $87.6 Million
Q1 2024

May 15, 2024
BUY
$22.09 - $35.41 $26.4 Million - $42.3 Million
1,194,292 Added 394.44%
1,497,071 $53 Million
Q4 2023

Feb 14, 2024
SELL
$14.28 - $31.03 $327,154 - $710,897
-22,910 Reduced 7.03%
302,779 $8.96 Million
Q3 2023

Nov 14, 2023
BUY
$19.33 - $36.22 $2.13 Million - $3.99 Million
110,049 Added 51.03%
325,689 $6.76 Million
Q2 2023

Aug 14, 2023
SELL
$24.18 - $42.46 $212,010 - $372,289
-8,768 Reduced 3.91%
215,640 $5.29 Million
Q1 2023

May 15, 2023
BUY
$35.86 - $46.5 $2.84 Million - $3.68 Million
79,241 Added 54.59%
224,408 $9.11 Million
Q4 2022

Feb 14, 2023
SELL
$35.49 - $56.15 $1.22 Million - $1.94 Million
-34,506 Reduced 19.2%
145,167 $6.53 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $68.97 $1.51 Million - $2.39 Million
34,583 Added 23.84%
179,673 $8.6 Million
Q2 2022

Aug 15, 2022
SELL
$53.22 - $123.09 $187,440 - $433,522
-3,522 Reduced 2.37%
145,090 $8.59 Million
Q1 2022

May 16, 2022
SELL
$101.89 - $150.09 $74,175 - $109,265
-728 Reduced 0.49%
148,612 $17.3 Million
Q4 2021

Feb 14, 2022
SELL
$118.18 - $153.21 $578,372 - $749,809
-4,894 Reduced 3.17%
149,340 $22.5 Million
Q3 2021

Nov 15, 2021
SELL
$93.51 - $129.4 $1.74 Million - $2.41 Million
-18,658 Reduced 10.79%
154,234 $18.4 Million
Q2 2021

Aug 16, 2021
SELL
$77.0 - $100.19 $161,084 - $209,597
-2,092 Reduced 1.2%
172,892 $16.8 Million
Q1 2021

May 17, 2021
SELL
$81.28 - $104.34 $93.6 Million - $120 Million
-1,150,967 Reduced 86.8%
174,984 $15.4 Million
Q4 2020

Feb 16, 2021
SELL
$86.4 - $121.75 $5.45 Million - $7.68 Million
-63,116 Reduced 4.54%
1,325,951 $127 Million
Q3 2020

Nov 13, 2020
BUY
$95.43 - $116.09 $9.09 Million - $11.1 Million
95,286 Added 7.36%
1,389,067 $158 Million
Q2 2020

Aug 14, 2020
BUY
$60.05 - $98.92 $21.5 Million - $35.4 Million
357,570 Added 38.19%
1,293,781 $128 Million
Q1 2020

May 15, 2020
SELL
$47.37 - $90.04 $23.6 Million - $44.9 Million
-498,795 Reduced 34.76%
936,211 $60.2 Million
Q4 2019

Feb 14, 2020
SELL
$53.13 - $71.19 $28 Million - $37.5 Million
-526,697 Reduced 26.85%
1,435,006 $85.5 Million
Q3 2019

Nov 14, 2019
SELL
$57.11 - $73.3 $12.3 Million - $15.8 Million
-215,252 Reduced 9.89%
1,961,703 $116 Million
Q2 2019

Aug 14, 2019
SELL
$54.41 - $71.7 $25.3 Million - $33.3 Million
-464,927 Reduced 17.6%
2,176,955 $140 Million
Q1 2019

May 14, 2019
SELL
$32.25 - $73.56 $17.5 Million - $39.9 Million
-542,198 Reduced 17.03%
2,641,882 $168 Million
Q4 2018

Feb 14, 2019
SELL
$28.45 - $40.65 $5.33 Million - $7.61 Million
-187,292 Reduced 5.56%
3,184,080 $121 Million
Q3 2018

Nov 14, 2018
BUY
$21.39 - $51.17 $30 Million - $71.7 Million
1,401,188 Added 71.12%
3,371,372 $144 Million
Q2 2018

Jul 19, 2018
BUY
$4.9 - $23.64 $9.56 Million - $46.1 Million
1,950,184 Added 9750.92%
1,970,184 $43.4 Million
Q1 2018

May 10, 2018
BUY
$2.35 - $4.96 $47,000 - $99,200
20,000 New
20,000 $99,000

Others Institutions Holding TNDM

# of Institutions
344
Shares Held
73.5M
Call Options Held
3.12M
Put Options Held
343K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.14B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email